Back to Agenda
Regulatory Affairs of the Future: Is Now
Session Chair(s)
Lina AlJuburi, PHARMD, MSC
Head, Regulatory Science and Policy, North America, Sanofi, United States
Global regulatory affairs is a critical function at the key interface between the innovation from our pipelines and patients. The world around us is changing very rapidly leading to implications and opportunities for regulatory affairs. We must evolve. But how?
Learning Objective : Identify what global changes are leading to an evolved regulatory affairs organization; Discuss what skillset global regulatory affairs professionals of the future will need.
Speaker(s)
M. Khair ElZarrad, PHD, MPH
Vice President, Regulatory Policy, BridgeBio, United States
FDA Update
Maria Florez, MA
Researcher, Pharma As Patients, United States
Academic Update
Nicole Mahoney, PHD
Executive Director US Regulatory Policy & Intelligence , Novartis, United States
Industry Update
Have an account?
